JAN 27, 2019 6:24 AM PST

Possible Biomarker Discovered for Schizophrenia

WRITTEN BY: Amy Loriaux

A study out of John's Hopkins University published by Dr. Robert Yolken, MD, and colleagues late last year have found a possible biomarker for schizophrenia. Biomarkers are extremely important to help diagnose disease, yet very few exist for psychiatric disorders. You cannot take a blood test to diagnose depression, for example. The current study found that schizophrenics carry a high level of a certain antibody produced in response to Epstein–Barr virus (EBV), a type of herpes virus that can lead to infectious mononucleosis (aka "mono" or "the kissing disease"). The schizophrenic patients in this study had a greater immune response to EBV-viral capsid antibody (VCA) compared to controls. 

Source: UnSplash.com

This is the first study to look at a connection between schizophrenia and EBV and suggests a possible biomarker for the disease. Many other studies have used neuroimaging, which has revealed structural and functional abnormalities in schizophrenia patients, to identify schizophrenics. Genetic studies have revealed a plethora of genetic abnormalities associated with schizophrenia. However, a brain scan may be financially out of reach for many patients with schizophrenia. Thus, a simpler biomarker test would benefit a larger proportion of patients.

The current study first measured levels of antibodies against EBV and found a higher level compared to healthy controls. EBV causes fever and swollen lymph nodes. It usually resolves in a couple weeks. However, in severe cases, it can spread to the central nervous system (CNS) and cause long-term infection. It is similar to how chicken pox in some young patients can "hide" in the CNS, only to emerge as shingles in old age. The researchers wanted to see whether EBV infection and schizophrenia were associated. 

Interestingly, schizophrenic patients did not have higher levels of antibodies against the chicken pox virus or herpes simplex type 1 (responsible for cold sores), both similar to EBV. These findings suggest that only EBV was associated with an increased risk of schizophrenia. 

Photo source: PixaBay.com

The idea of an immunological cause of schizophrenia is not new. A comprehensive review coming out of King's College London found a significant relationship between non-neuronal autoimmune diseases and psychosis. It has been known for some time now that infections early in life can cause autoimmune disorders. These pieces of evidence from multiple labs lead credence to the theory that infectious disease could potentially cause schizophrenia. 

The present study out of John's Hopkins found only a positive correlation between schizophrenia and high levels of antibodies to EBV. Causation cannot be determined by their data. Dr. Yolken cautioned that the study "wasn’t designed to determine cause and effect." Theoretical causes to explain this correlation include: (1) EBV infection can cause schizophrenia or contribute to its development; (2) schizophrenic patients are prone to have an increased response to EBV; or (3) something else (genetics, environmental) causes schizophrenia and increased susceptibility to EBV. More research is needed to dissociate causation from correlation.

Sources: Schizophrenia BulletinBiological Psychiatry. Cognitive Neuroscience and Neuroimaging, The Australian and New Zealand Journal of Psychiatry, Nature, NeuroscienceNews.com, Biological Psychiatry, Seminars in Immunology

About the Author
PhD
I currently work at a small CRO involved in clinical trial management.
You May Also Like
JUN 10, 2022
Neuroscience
Scientists Develop Neurobiological Model to Explore Creativity and Neural Networks
JUN 10, 2022
Scientists Develop Neurobiological Model to Explore Creativity and Neural Networks
A study published in Neuroscience found that different areas of the brain are activated depending on the type of creativ ...
JUN 28, 2022
Neuroscience
Processing Sad Emotions
JUN 28, 2022
Processing Sad Emotions
A study published in Communications Biology focused on the neural mechanisms of the pons-corticolimbic network, with spe ...
JUN 29, 2022
Neuroscience
How the Brain Makes Sense of Self -Motion While Observing an Object in Motion
JUN 29, 2022
How the Brain Makes Sense of Self -Motion While Observing an Object in Motion
University of Rochester researchers published a study in eLife in which they examined a novel neural mechanism involved ...
JUL 15, 2022
Cannabis Sciences
What THC and CBD Really Taste Like
JUL 15, 2022
What THC and CBD Really Taste Like
Do THC and CBD have any kind of taste? What is it like?
AUG 16, 2022
Drug Discovery & Development
Blood Pressure Drug Shows Promise for Treating ALS
AUG 16, 2022
Blood Pressure Drug Shows Promise for Treating ALS
Terazosin, a drug currently approved to treat high blood pressure and enlarged prostate, may also be able to treat ALS. ...
AUG 17, 2022
Neuroscience
The Research Value of Patient Medical Records and Samples
AUG 17, 2022
The Research Value of Patient Medical Records and Samples
A majority of patients want notification about the potential uses of their medical records or samples according to a stu ...
Loading Comments...